000 02197 a2200577 4500
005 20250514023920.0
264 0 _c20020611
008 200206s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.46.3.731-738.2002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaguire, Michael
245 0 0 _aEmergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cMar 2002
300 _a731-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aCarbamates
650 0 4 _aCloning, Molecular
650 0 4 _aDrug Resistance, Microbial
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFurans
650 0 4 _aGenotype
650 0 4 _aHIV Core Protein p24
_xdrug effects
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV Protease
_xgenetics
650 0 4 _aHIV Protease Inhibitors
_xtherapeutic use
650 0 4 _aHIV Reverse Transcriptase
_xantagonists & inhibitors
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMutagenesis, Site-Directed
650 0 4 _aNucleosides
_xpharmacology
650 0 4 _aPhenotype
650 0 4 _aRNA, Viral
_xchemistry
650 0 4 _aReverse Transcriptase Inhibitors
_xtherapeutic use
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSulfonamides
_xtherapeutic use
700 1 _aShortino, Denise
700 1 _aKlein, Astrid
700 1 _aHarris, Wendy
700 1 _aManohitharajah, Varsha
700 1 _aTisdale, Margaret
700 1 _aElston, Robert
700 1 _aYeo, Jane
700 1 _aRandall, Sharon
700 1 _aXu, Fan
700 1 _aParker, Hayley
700 1 _aMay, Jackie
700 1 _aSnowden, Wendy
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 46
_gno. 3
_gp. 731-8
856 4 0 _uhttps://doi.org/10.1128/AAC.46.3.731-738.2002
_zAvailable from publisher's website
999 _c11758718
_d11758718